Rhythm Pharmaceuticals (RYTM)
(Delayed Data from NSDQ)
$44.03 USD
-0.16 (-0.36%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $44.02 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: BMO |
6/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, Rhythm Pharmaceuticals (RYTM) reported earnings of -$2.35 per share, missing the Zacks Consensus Estimate of -$2.34 per share. This reflects a negative earnings surprise of 0.43%. Look out for RYTM's next earnings release on August 06, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year increase of 14.63%.
Earnings History
Price & Consensus
Zacks News for RYTM
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
RYTM: What are Zacks experts saying now?
Zacks Private Portfolio Services